RVPH 8-K: SEC filing
Filed with the SEC on · accession 0001437749-26-036647
RVPH filed a 8-K (current report) with the SEC on Nov 13, 2026. Reviva Pharmaceuticals furnished an 8-K disclosing financial information and operating metrics for its fiscal quarter ended September 30, 2026, along with a business outlook update via press release.
Summary of the filing
Reviva Pharmaceuticals furnished an 8-K disclosing financial information and operating metrics for its fiscal quarter ended September 30, 2026, along with a business outlook update via press release. The filing also notes the company's common stock is now quoted on OTCQB after its Nasdaq delisting.
Key details
✦ Ask GOAX AI about this filing — what it means for RVPH, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for RVPH?
Click hereFrequently asked questions
What did RVPH file with the SEC on Nov 13, 2026?
RVPH filed a 8-K (SEC filing). Reviva Pharmaceuticals furnished an 8-K disclosing financial information and operating metrics for its fiscal quarter ended September 30, 2026, along with a business outlook update via press release. The filing also notes the company's common stock is now quoted on OTCQB after its Nasdaq delisting.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other RVPH SEC filings
Get alerts when RVPH files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days